BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
KRChoksey Report
Result Highlights of Q2 FY24:
For Q2 FY24, Balaji Amines Ltd. revenue declined by 39.4% YoY and 17.9% QoQ to Rs 3,805 million while for H1 FY24 revenue declined by 34.9% YoY to Rs 8,442 million. This heavy decline in sales is due to a drop in price realization and destocking among global companies.
Adjusted Ebitda declined by 68.9% YoY and 45.1% QoQ to Rs 538 million while for H1 FY24 Adj Ebitda declined by 60.9% YoY to Rs 1,518 million. Adj Ebitda margin contracted 1,345 basis points YoY and 701 bps QoQ to 14.1% while for H1 FY24 Adj Ebitda margin contracted 1191 bps to 18.0%. This was due to intense competition from China and usage of high cost inventory.
Profit after tax declined by 62.5% YoY and 34.2% QoQ to Rs 347 million while for H1 FY24 PAT declined by 59.4% YoY to Rs 874 million. PAT margin contracted 563 bps YoY and 225 bps QoQ to 9.1% while for H1 FY24 PAT margin contracted 625 bps to 10.4%. This quarterly decline is due to weak operating performance.
Click on the attachment to read the full report:
Also Read: Aurobindo Pharma Q2 Results Review - Margin Outlook Optimistic Led By Better Product Mix: KRChoksey
DISCLAIMER
This report is authored by an external party. BQ Prime does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BQ Prime.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
RECOMMENDED FOR YOU
Balaji Amines In Final Stages of Negotiation With Lithium Battery Manufacturer: Managing Director
![timelogo](/images/amp-time.png)
![](https://images.assettype.com/bloombergquint/2024-05/73b1e5d4-f9a3-4dd4-bc04-6cf509e46761/Balaji_Amines_website.jpg?rect=0%2C0%2C3500%2C1969&auto=format%2Ccompress&format=webp&w=75)
Balaji Amines Q1 Results Review - Lack Of Demand In Agrochem Impacted The Quarterly Performance: DRChoksey
![timelogo](/images/amp-time.png)
![](https://images.assettype.com/bloombergquint/2022-05/255b1cca-d577-4173-b246-2802371a5885/Hindalco_Novelis__Source_Company_website_.png?rect=0%2C0%2C3500%2C1969&auto=format%2Ccompress&format=webp&w=75)
Novelis Q1 Results: Operating Income Rises 19% To $500 Million
![timelogo](/images/amp-time.png)
![](https://images.assettype.com/bloombergquint/2024-08-07/aefko3qu/pavel-neznanov-jSMvAmew4Wo-unsplash.jpg?rect=0%2C0%2C3500%2C1969&auto=format%2Ccompress&format=webp&w=75)
Balaji Amines Q1 Results: Profit Down 33%, Misses Estimates
![timelogo](/images/amp-time.png)